Business Context and Reporting Period
This Form 8-K Current Report from Clarivate Plc covers events occurring on September 9, 2021, with the report filed on September 14, 2021. The filing details the entry into a material definitive agreement regarding a registered public offering of ordinary shares by certain existing shareholders.
Key Financial Metrics and Transaction Details
- Transaction Type: Secondary offering of 25,000,000 ordinary shares by Selling Shareholders.
- Underwriters: Citigroup Global Markets Inc. as representative.
- Over-Allotment Option: A 30-day option granted to underwriters to purchase up to an additional 3,750,000 ordinary shares.
- Company Proceeds: The filing explicitly states that Clarivate Plc will not receive any proceeds from this sale.
- Financial Statements: This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing text does not provide a clear value for these items.
Material Changes
The primary material change is the execution of an underwriting agreement on September 9, 2021, and the subsequent closing of the offering on September 14, 2021. This transaction results in a change in the company's shareholder base but does not alter the company's capital structure or cash position directly.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to the company's operational outlook. The only noted contingency is the 30-day over-allotment option held by the underwriters. The description of the agreement is qualified by reference to the full Underwriting Agreement included as Exhibit 1.1.
Investor Verification Checklist
- Verify the identity of the "Selling Shareholders" listed in Schedule B of the Underwriting Agreement (Exhibit 1.1).
- Confirm the final offering price per share and total gross proceeds to the selling shareholders, which are not detailed in the summary text of this 8-K.
- Monitor whether the underwriters exercise the 3,750,000 share over-allotment option within the 30-day window.
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up provisions or other covenants affecting the selling shareholders.